Assurant Announces Leadership Changes in Europe and Latin America
Assurant, Inc. (NYSE: AIZ), a leading global business services company that supports, protects, and connects major consumer purchases, today announced leadership changes in Europe and Latin America.
"Assurant’s unwavering commitment to best-in-class talent around the world and strengthening global mobility has built a strong leadership team and bench, enabling seamless international transitions and strategically accelerating our business growth," said Subhashish Sengupta, Chief People Officer, Assurant. “These appointments underscore the success of our talent investments and our dedication to nurturing future leaders and advancing global excellence."
Today, Assurant announced the appointment of Felipe Sanchez as its new president, Europe, subject to receipt of regulatory approval. Sanchez will have responsibility for Assurant’s European strategy to deliver growth in France, Germany, Italy, Netherlands, Spain, and the United Kingdom (UK). He brings exceptional leadership, global vision, and proven expertise in driving innovation and business development to this new role.
Sanchez, who joined the company as president, Assurant Mexico, led impressive results in Global Auto and Connected Living, driving growth in Latin America. With more than 30 years of experience in executive leadership, business and marketing management, and strategic planning, he has built high-performing teams across the Caribbean, Central America, and the United States. Sanchez will report to Federico Bunge, president, International.
Sanchez succeeds Christian Formby, who after five years as European president, has been appointed president, Specialty Solutions, Global Housing, which includes Manufactured Housing, Condominium and other related product lines. Christian’s success managing Assurant’s European business and Global Housing experience will be essential to driving Property Solutions business growth. Christian will report to Mike Campbell, president, Global Housing.
As the appointment of Sanchez is subject to receipt of regulatory approval from the UK Financial Services Regulators, during this transitional period, Formby will retain regulatory responsibility.
After six years as president of Assurant in Argentina, Diego Gomez will be appointed president of Assurant Mexico. Gomez led Assurant Argentina as CEO, and he brought vision and strategic leadership to the company. Under Gomez’s leadership, Assurant Argentina opened the first Global Capabilities Center (GCC) in Buenos Aires, which has brought new jobs, opportunities, and career advancement for our employees. Gomez has 20 years of experience at Assurant in insurance and related services, leading teams in Latin America and Europe. Before being appointed country manager for Argentina, Gomez developed an impressive career including roles as LatAm COO and Chief Risk Officer, European COO and actuarial manager in Argentina. Gomez will continue to report into Ricardo Fiuza, president, Latin America.
Ines Aramburu is appointed president of Assurant Argentina. Most recently as vice president of Assurant International’s People organization, Aramburu facilitated international development by aligning talent with business priorities and creating and delivering global programs, while supporting significant growth projects. Aramburu was instrumental to launching Assurant’s Argentina GCC, while also playing a key role in opening Assurant’s second GCC in India. By fostering global collaboration, Aramburu effectively matched talent and expertise to support business transformation initiatives in all of Assurant’s International regions. Aramburu will report directly to Ricardo Fiuza.
"At the heart of Assurant is our people, and we are committed to developing our talent, ensuring a strong leadership team with diverse expertise. Felipe, Diego, and Ines are visionary leaders with extensive experience and success. They will drive our strategic initiatives and maintain the high standards of excellence that our clients expect," said Sengupta.
# # #
About Assurant
Assurant, Inc. (NYSE: AIZ) is a leading global business services company that supports, protects and connects major consumer purchases. A Fortune 500 company with a presence in 21 countries, Assurant supports the advancement of the connected world by partnering with the world’s leading brands to develop innovative solutions and to deliver an enhanced customer experience through mobile device solutions, extended service contracts, vehicle protection services, renters insurance, lender-placed insurance products and other products.
Learn more at assurant.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250130279393/en/
Contacts
Media:
Lorraine Doherty
Director Communications, International
lorraine.doherty@assurant.com - stacie.sherer@assurant.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Coincheck Group N.V. to Announce Third Quarter 2025 Results on February 12, 202531.1.2025 15:30:00 EET | Press release
Coincheck Group N.V. (the “Company”) (Nasdaq: CNCK), the holding company for Coincheck, Inc, a leading Japanese crypto exchange, today announced that the Company will release its third quarter 2025 financial results on Wednesday, February 12, 2025. The Company will host a conference call to discuss third quarter 2025 financial results at 5:00 pm ET that same day. Hosting the call will be Oki Matsumoto, Executive Chairman, Gary Simanson, Chief Executive Officer, and Jason Sandberg, Chief Financial Officer. The call will be webcast live from the Company's website at www.coincheckgroup.com. A replay will be available on the Company’s investor relations website following the call. The conference call can also be accessed over the phone by dialing (877) 407-4018 or (201) 689-8471; the Conference ID is 13751285. About Coincheck Group N.V. Headquartered in the Netherlands, Coincheck Group N.V. (NASDAQ: CNCK) is a public limited liability company and the holding company for Coincheck, Inc. Coi
Datopotamab Deruxtecan Recommended for Approval in the EU by CHMP for Patients with Previously Treated Metastatic HR Positive, HER2 Negative Breast Cancer31.1.2025 15:00:00 EET | Press release
Datopotamab deruxtecan (Dato-DXd) has been recommended for approval in the European Union (EU) for the treatment of adult patients with unresectable or metastatic hormone receptor (HR) positive, HER2 negative (IHC 0, IHC 1+ or IHC 2+/ISH-) breast cancer who have received endocrine therapy and at least one line of chemotherapy in the advanced setting. Datopotamab deruxtecan is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE:45680) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/Nasdaq: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the TROPION-Breast01 phase 3 trial published in the Journal of Clinical Oncology. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In TROPION-Breast01, datopot
REPLY: Coding and Cybersecurity, Registration Is Now Open for the Reply Hack The Code Challenge 202531.1.2025 13:42:00 EET | Press release
Reply has announced the opening of registrations for the ReplyHackThe Code Challenge 2025, the leading online team coding competition, which will take place on March 12th 2025. This year's challenge will combine programming and cybersecurity for the first time, offering participants the opportunity to tackle algorithmic problems and cybersecurity challenges. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250131992792/en/ Reply has announced the opening of registrations for the Reply Hack The Code Challenge 2025, the leading online team coding competition, which will take place on March 12th 2025. This year's challenge will combine programming and cybersecurity for the first time, offering participants the opportunity to tackle algorithmic problems and cybersecurity challenges. (Photo: Business Wire) The competition follows the format of previous events, with two parallel challenges: the Standard Edition, aimed at university
GE HealthCare Invests $138 Million in Cork, Ireland Manufacturing Facility to Address Increasing Contrast Media Demand31.1.2025 10:00:00 EET | Press release
GE HealthCare (Nasdaq: GEHC) today announced a $138 million investment to expand its Carrigtohill, Cork contrast media fill and finish manufacturing site in Ireland. A new state-of-the-art facility on the grounds of the existing site will enable 25 million more patient doses per year of contrast media by the end of 2027, helping address growing global demand. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250130241464/en/ GE HealthCare’s contrast media manufacturing site in Cork (Photo: Business Wire) Contrast media are injectable diagnostic imaging agents used to enhance visualization of organs, blood vessels and tissues during medical imaging. Global demand for iodine-based contrast media, used in X-Ray, Computed Tomography (CT) and Interventional procedures is expected to double in the next decade, driven by ageing populations and the increasing global prevalence of chronic disorders. In 2024, the Carrigtohill facility, a
Vertex Announces CASGEVY ® Reimbursement Agreement for the Treatment of Sickle Cell Disease in England31.1.2025 09:00:00 EET | Press release
Vertex Pharmaceuticals (Nasdaq: VRTX) announced today a reimbursement agreement with NHS England for eligible sickle cell disease (SCD) patients to access the CRISPR/Cas9 gene-edited therapy, CASGEVY® (exagamglogene autotemcel). The reimbursement agreement comes as the National Institute for Health and Care Excellence (NICE) issues positive guidance recommending CASGEVY’s use in the NHS. It means that eligible SCD patients in England now have access to the therapy following the prior agreement for transfusion-dependent beta thalassemia (TDT) patients announced last August. “Today is an important day for the sickle cell community who have gone too long without treatments that address the underlying cause of their devastating disease,” said Ludovic Fenaux, Senior Vice President, Vertex International. “We are pleased to have reached this new agreement that ensures both eligible SCD and TDT patients can now be treated with CASGEVY, recognizing the value a one-time treatment can provide to
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom